Intravenous news: MailOnline report : “Millions of NHS patients could be at risk after they received treatment based on ‘fraudulent research’ by one of the world’s leading anaesthetists, it has emerged.
Joachim Boldt, 57, is accused of forging up to 90 influential studies on fluid drugs known as colloids, used to boost blood volume in patients going under the knife.
The anaesthetist, who is a specialist in intravenous fluid management, was sacked from his job at German Ludwigshafen Hospital last November amid the allegations.
Over the last ten years he has published many papers advocating colloids which contradicted other studies highlighting their risks, which include kidney or heart failure and severe loss of blood – all of which could lead to death in surgery.
Now four key colloid studies – on which guidelines for British anaesthetists are based – have been formally retracted shaking the medical world to its core. A number of British journals have also run Mr Boldt’s Consensus Guidelines on Intravenous Fluid Therapy advocating the drugs, including the Association of Surgeons and the Intensive Care Society.
Association president Prof John MacFie told the Daily Telegraph: ‘We have withdrawn the guidelines from our website and we will need to rewrite the article.”